AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

RECCE PHARMACEUTICALS LTD

0.605

-0.005-0.82%

Volume:13.28K

Turnover:7.99K

Market Cap:174.96M

PE:-6.69

High:0.610

Open:0.610

Low:0.595

Close:0.610

52wk High:0.730

52wk Low:0.275

Shares:289.18M

Float Shares:168.89M

Volume Ratio:0.43

T/O Rate:0.01%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.090

EPS(LYR):-0.090

ROE:-1277.62%

ROA:-135.80%

PB:-57.32

PE(LYR):-6.69

Loading ...

Overview Company News Filings

Company Profile

Company Name:

RECCE PHARMACEUTICALS LTD

Exchange:

ASX

Establishment Date:

2007

Employees:

- -

Office Location:

Governor Macquarie Tower,Level 15,1 Farrer Place,Sydney,New South Wales,Australia

Website:

http://www.recce.com.au

Zip Code:

2000

Phone:

Fax:

- -

Introduction:

Recce Pharmaceuticals Ltd, a biotechnology company, engages in the research, development, and commercialization of antibiotics in Australia and the United States. Its lead candidate is RECCE 327 to treat blood infections and sepsis derived from E. coli and S. aureus bacteria, including their superbug forms. The company was formerly known as Recce Limited and changed its name to Recce Pharmaceuticals Ltd in November 2017. Recce Pharmaceuticals Ltd was incorporated in 2007 and is headquartered in Sydney, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RCE.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"RCE.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RCE.AU\",,,,,undefined,":{"symbol":"RCE.AU","market":"AU","secType":"STK","nameCN":"RECCE PHARMACEUTICALS LTD","latestPrice":0.605,"timestamp":1770776000040,"preClose":0.61,"halted":0,"volume":13281,"delay":0,"changeRate":-0.008196721311475417,"nameEN":"RECCE PHARMACEUTICALS LTD","floatShares":168893037,"shares":289183422,"eps":-0.090423,"marketStatus":"Trading","change":-0.005,"latestTime":"02-11 13:16:12 AEDT","open":0.61,"high":0.61,"low":0.595,"amount":7993,"amplitude":0.02459,"askPrice":0.61,"askSize":48118,"bidPrice":0.6,"bidSize":9900,"shortable":3,"etf":0,"ttmEps":-0.090423,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1770786000000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.61,"openAndCloseTimeList":[[1770764400000,1770786000000]],"volumeRatio":0.426501,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RCE.AU\",,,,,undefined,":{"symbol":"RCE.AU","floatShares":168893037,"roa":"-135.80%","roe":"-1277.62%","lyrEps":-0.090423,"volumeRatio":0.426501,"shares":289183422,"dividePrice":0,"high":0.61,"amplitude":0.02459,"preClose":0.61,"low":0.595,"week52Low":0.275,"pbRate":"-57.32","psRate":"23.30","week52High":0.73,"institutionHeld":0,"latestPrice":0.605,"committee":-0.658727,"eps":-0.090423,"divideRate":0,"volume":13281,"delay":0,"ttmEps":-0.090423,"open":0.61,"prevYearClose":0.65,"prevWeekClose":0.57,"prevMonthClose":0.56,"prevQuarterClose":0.65,"fiveDayClose":0.575,"twentyDayClose":0.67,"sixtyDayClose":0.445,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RCE.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-04-15","symbol":"RCE.AU","defaultRemindTime":1744675200000,"type":"split","dateTimestamp":1744639200000,"forFactor":990476,"toFactor":1000000,"ratio":0.990476}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RCE.AU\",market:\"AU\",,,undefined,":[],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":310479285,"yearFounded":2007,"address":"Governor Macquarie Tower,Level 15,1 Farrer Place,Sydney,New South Wales,Australia","zipCode":"2000","officePhone":"61 2 9000 1907"},"stockCompanyDetail":{"websiteUrl":"http://www.recce.com.au","stockEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":-0.0687},{"period":"3month","weight":0.4186},{"period":"6month","weight":0.4023},{"period":"1year","weight":0.3991},{"period":"ytd","weight":-0.0615}],"compareEarnings":[{"period":"1week","weight":-0.0046},{"period":"1month","weight":-0.0033},{"period":"3month","weight":0.0114},{"period":"6month","weight":0.0682},{"period":"1year","weight":0.2023},{"period":"ytd","weight":0.0074}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Recce Pharmaceuticals Ltd, a biotechnology company, engages in the research, development, and commercialization of antibiotics in Australia and the United States. Its lead candidate is RECCE 327 to treat blood infections and sepsis derived from E. coli and S. aureus bacteria, including their superbug forms. The company was formerly known as Recce Limited and changed its name to Recce Pharmaceuticals Ltd in November 2017. Recce Pharmaceuticals Ltd was incorporated in 2007 and is headquartered in Sydney, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.272727,"avgChangeRate":-0.061616},{"month":2,"riseRate":0.1,"avgChangeRate":-0.046151},{"month":3,"riseRate":0.6,"avgChangeRate":0.093758},{"month":4,"riseRate":0.4,"avgChangeRate":0.137823},{"month":5,"riseRate":0.5,"avgChangeRate":-0.023787},{"month":6,"riseRate":0.5,"avgChangeRate":0.109046},{"month":7,"riseRate":0.4,"avgChangeRate":-0.027543},{"month":8,"riseRate":0.4,"avgChangeRate":0.04119},{"month":9,"riseRate":0.2,"avgChangeRate":-0.083267},{"month":10,"riseRate":0.5,"avgChangeRate":0.015341},{"month":11,"riseRate":0.5,"avgChangeRate":0.092476},{"month":12,"riseRate":0.3,"avgChangeRate":0.008161}],"exchange":"ASX","name":"RECCE PHARMACEUTICALS LTD","nameEN":"RECCE PHARMACEUTICALS LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"RCE.AU\",market:\"AU\",,,undefined,":null}}